Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 595

1.

Left ventricular hypertrophy patterns and incidence of heart failure with preserved versus reduced ejection fraction.

Velagaleti RS, Gona P, Pencina MJ, Aragam J, Wang TJ, Levy D, D'Agostino RB, Lee DS, Kannel WB, Benjamin EJ, Vasan RS.

Am J Cardiol. 2014 Jan 1;113(1):117-22. doi: 10.1016/j.amjcard.2013.09.028. Epub 2013 Oct 4.

2.

Association of physical activity and heart failure with preserved vs. reduced ejection fraction in the elderly: the Framingham Heart Study.

Kraigher-Krainer E, Lyass A, Massaro JM, Lee DS, Ho JE, Levy D, Kannel WB, Vasan RS.

Eur J Heart Fail. 2013 Jul;15(7):742-6. doi: 10.1093/eurjhf/hft025. Epub 2013 Feb 22.

3.

Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction.

Ho JE, Lyass A, Lee DS, Vasan RS, Kannel WB, Larson MG, Levy D.

Circ Heart Fail. 2013 Mar;6(2):279-86. doi: 10.1161/CIRCHEARTFAILURE.112.972828. Epub 2012 Dec 27.

4.

Discriminating clinical features of heart failure with preserved vs. reduced ejection fraction in the community.

Ho JE, Gona P, Pencina MJ, Tu JV, Austin PC, Vasan RS, Kannel WB, D'Agostino RB, Lee DS, Levy D.

Eur Heart J. 2012 Jul;33(14):1734-41. doi: 10.1093/eurheartj/ehs070. Epub 2012 Apr 16.

5.

Sixty years of preventive cardiology: a Framingham perspective.

Kannel WB.

Clin Cardiol. 2011 Jun;34(6):342-3. doi: 10.1002/clc.20923. No abstract available.

6.

Higher aldosterone and lower N-terminal proatrial natriuretic peptide as biomarkers of salt sensitivity in the community.

Lieb W, Pencina MJ, Jacques PF, Wang TJ, Larson MG, Levy D, Kannel WB, Vasan RS.

Eur J Cardiovasc Prev Rehabil. 2011 Aug;18(4):664-73. doi: 10.1177/1741826710389406. Epub 2011 Feb 11.

7.

Efficacy of dietary behavior modification for preserving cardiovascular health and longevity.

Pryde MM, Kannel WB.

Cardiol Res Pract. 2010 Dec 28;2011:820457. doi: 10.4061/2011/820457.

8.

Validation of an atrial fibrillation risk algorithm in whites and African Americans.

Schnabel RB, Aspelund T, Li G, Sullivan LM, Suchy-Dicey A, Harris TB, Pencina MJ, D'Agostino RB Sr, Levy D, Kannel WB, Wang TJ, Kronmal RA, Wolf PA, Burke GL, Launer LJ, Vasan RS, Psaty BM, Benjamin EJ, Gudnason V, Heckbert SR.

Arch Intern Med. 2010 Nov 22;170(21):1909-17. doi: 10.1001/archinternmed.2010.434.

9.

A systematic assessment of causes of death after heart failure onset in the community: impact of age at death, time period, and left ventricular systolic dysfunction.

Lee DS, Gona P, Albano I, Larson MG, Benjamin EJ, Levy D, Kannel WB, Vasan RS.

Circ Heart Fail. 2011 Jan;4(1):36-43. doi: 10.1161/CIRCHEARTFAILURE.110.957480. Epub 2010 Nov 11.

10.

Framingham study insights on diabetes and cardiovascular disease.

Kannel WB.

Clin Chem. 2011 Feb;57(2):338-9. doi: 10.1373/clinchem.2010.149740. Epub 2010 Sep 13. No abstract available.

11.

Relations of serum phosphorus levels to echocardiographic left ventricular mass and incidence of heart failure in the community.

Dhingra R, Gona P, Benjamin EJ, Wang TJ, Aragam J, D'Agostino RB Sr, Kannel WB, Vasan RS.

Eur J Heart Fail. 2010 Aug;12(8):812-8. doi: 10.1093/eurjhf/hfq106.

12.

Relations of lipid concentrations to heart failure incidence: the Framingham Heart Study.

Velagaleti RS, Massaro J, Vasan RS, Robins SJ, Kannel WB, Levy D.

Circulation. 2009 Dec 8;120(23):2345-51. doi: 10.1161/CIRCULATIONAHA.109.830984. Epub 2009 Nov 23.

13.

Is age really a non-modifiable cardiovascular risk factor?

Kannel WB, Vasan RS.

Am J Cardiol. 2009 Nov 1;104(9):1307-10. doi: 10.1016/j.amjcard.2009.06.051. No abstract available.

14.

Strategies for cardiovascular risk assessment and prevention over the life course: progress amid imperfections.

Vasan RS, Kannel WB.

Circulation. 2009 Aug 4;120(5):360-3. doi: 10.1161/CIRCULATIONAHA.109.881995. Epub 2009 Jul 20. No abstract available.

PMID:
19620497
15.

Hypertension: reflections on risks and prognostication.

Kannel WB.

Med Clin North Am. 2009 May;93(3):541-58, Table of Contents. doi: 10.1016/j.mcna.2009.02.006. Review.

16.

Triglycerides as vascular risk factors: new epidemiologic insights.

Kannel WB, Vasan RS.

Curr Opin Cardiol. 2009 Jul;24(4):345-50. doi: 10.1097/HCO.0b013e32832c1284. Review.

17.

Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study.

Schnabel RB, Sullivan LM, Levy D, Pencina MJ, Massaro JM, D'Agostino RB Sr, Newton-Cheh C, Yamamoto JF, Magnani JW, Tadros TM, Kannel WB, Wang TJ, Ellinor PT, Wolf PA, Vasan RS, Benjamin EJ.

Lancet. 2009 Feb 28;373(9665):739-45. doi: 10.1016/S0140-6736(09)60443-8.

18.

Systematically missing confounders in individual participant data meta-analysis of observational cohort studies.

Fibrinogen Studies Collaboration, Jackson D, White I, Kostis JB, Wilson AC, Folsom AR, Wu K, Chambless L, Benderly M, Goldbourt U, Willeit J, Kiechl S, Yarnell JW, Sweetnam PM, Elwood PC, Cushman M, Psaty BM, Tracy RP, Tybjaerg-Hansen A, Haverkate F, de Maat MP, Thompson SG, Fowkes FG, Lee AJ, Smith FB, Salomaa V, Harald K, Rasi V, Vahtera E, Jousilahti P, D'Agostino R, Kannel WB, Wilson PW, Tofler G, Levy D, Marchioli R, Valagussa F, Rosengren A, Wilhelmsen L, Lappas G, Eriksson H, Cremer P, Nagel D, Curb JD, Rodriguez B, Yano K, Salonen J, Nyyssönen K, Tuomainen TP, Hedblad B, Engström G, Berglund G, Loewel H, Koenig W, Hense HW, Meade TW, Cooper JA, De Stavola B, Knottenbelt C, Miller GJ, Cooper JA, Bauer KA, Rosenberg RD, Sato S, Kitamura A, Naito Y, Iso H, Salomaa V, Harald K, Rasi V, Vahtera E, Jousilahti P, Palosuo T, Ducimetiere P, Amouyel P, Arveiler D, Evans AE, Ferrieres J, Juhan-Vague I, Bingham A, Schulte H, Assmann G, Cantin B, Lamarche B, Despres JP, Dagenais GR, Tunstall-Pedoe H, Lowe GD, Woodward M, Ben-Shlomo Y, Davey Smith G, Palmieri V, Yeh JL, Meade TW, Rudnicka A, Brennan P, Knottenbelt C, Cooper JA, Ridker P, Rodeghiero F, Tosetto A, Shepherd J, Lowe GD, Ford I, Robertson M, Brunner E, Shipley M, Feskens EJ, Di Angelantonio E, Kaptoge S, Lewington S, Lowe GD, Sarwar N, Thompson SG, Walker M, Watson S, White IR, Wood AM, Danesh J.

Stat Med. 2009 Apr 15;28(8):1218-37. doi: 10.1002/sim.3540.

19.

Adverse consequences of the 50% misconception.

Kannel WB, Vasan RS.

Am J Cardiol. 2009 Feb 1;103(3):426-7. doi: 10.1016/j.amjcard.2008.09.098. Epub 2008 Nov 27.

20.

Plasma leptin levels and incidence of heart failure, cardiovascular disease, and total mortality in elderly individuals.

Lieb W, Sullivan LM, Harris TB, Roubenoff R, Benjamin EJ, Levy D, Fox CS, Wang TJ, Wilson PW, Kannel WB, Vasan RS.

Diabetes Care. 2009 Apr;32(4):612-6. doi: 10.2337/dc08-1596. Epub 2008 Dec 29.

21.

Current perceptions of the epidemiology of atrial fibrillation.

Kannel WB, Benjamin EJ.

Cardiol Clin. 2009 Feb;27(1):13-24, vii. doi: 10.1016/j.ccl.2008.09.015. Review.

22.

Framingham Study insights on the hazards of elevated blood pressure.

Kannel WB, Wolf PA.

JAMA. 2008 Dec 3;300(21):2545-7. doi: 10.1001/jama.2008.759. No abstract available.

PMID:
19050198
23.

Genetics of the Framingham Heart Study population.

Govindaraju DR, Adrienne Cupples L, Kannel WB, O'Donnell CJ, Atwood LD, D'Agostino RB Sr, Fox CS, Larson M, Levy D, Murabito J, Vasan RS, Lee Splansky G, Wolf PA, Benjamin EJ.

Adv Genet. 2008;62:33-65. doi: 10.1016/S0065-2660(08)00602-0. Review.

24.

Long-term trends in the incidence of heart failure after myocardial infarction.

Velagaleti RS, Pencina MJ, Murabito JM, Wang TJ, Parikh NI, D'Agostino RB, Levy D, Kannel WB, Vasan RS.

Circulation. 2008 Nov 11;118(20):2057-62. doi: 10.1161/CIRCULATIONAHA.108.784215. Epub 2008 Oct 27.

25.

Reflections on the utility of imaging for prevention of coronary disease.

Kannel WB, Vasan RS.

Am J Cardiol. 2008 Oct 15;102(8):1116. doi: 10.1016/j.amjcard.2008.08.003. No abstract available.

26.

Interindividual variation in serum sodium and longitudinal blood pressure tracking in the Framingham Heart Study.

Lago RM, Pencina MJ, Wang TJ, Lanier KJ, D'Agostino RB, Kannel WB, Vasan RS.

J Hypertens. 2008 Nov;26(11):2121-5. doi: 10.1097/HJH.0b013e32830fe4a5.

27.

Challenges to consider in practicing specialized medicine.

Kannel WB.

Ochsner J. 2008 Fall;8(3):105-7. No abstract available.

PMID:
21603460
Free PMC Article
28.

Altered blood pressure progression in the community and its relation to clinical events.

Ingelsson E, Gona P, Larson MG, Lloyd-Jones DM, Kannel WB, Vasan RS, Levy D.

Arch Intern Med. 2008 Jul 14;168(13):1450-7. doi: 10.1001/archinte.168.13.1450.

29.

Beyond established and novel risk factors: lifestyle risk factors for cardiovascular disease.

Mozaffarian D, Wilson PW, Kannel WB.

Circulation. 2008 Jun 10;117(23):3031-8. doi: 10.1161/CIRCULATIONAHA.107.738732. Review. No abstract available.

PMID:
18541753
30.

Angina pectoris is a stronger indicator of diffuse vascular atherosclerosis than intermittent claudication: Framingham study.

Kannel WB, Evans JC, Piper S, Murabito JM.

J Clin Epidemiol. 2008 Sep;61(9):951-7. doi: 10.1016/j.jclinepi.2007.10.025. Epub 2008 May 20.

31.
32.

Prediction of intermittent claudication, ischemic stroke, and other cardiovascular disease by detection of abdominal aortic calcific deposits by plain lumbar radiographs.

Levitzky YS, Cupples LA, Murabito JM, Kannel WB, Kiel DP, Wilson PW, Wolf PA, O'Donnell CJ.

Am J Cardiol. 2008 Feb 1;101(3):326-31. doi: 10.1016/j.amjcard.2007.08.032.

PMID:
18237594
33.

General cardiovascular risk profile for use in primary care: the Framingham Heart Study.

D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB.

Circulation. 2008 Feb 12;117(6):743-53. doi: 10.1161/CIRCULATIONAHA.107.699579. Epub 2008 Jan 22.

PMID:
18212285
34.

A risk score for predicting near-term incidence of hypertension: the Framingham Heart Study.

Parikh NI, Pencina MJ, Wang TJ, Benjamin EJ, Lanier KJ, Levy D, D'Agostino RB Sr, Kannel WB, Vasan RS.

Ann Intern Med. 2008 Jan 15;148(2):102-10.

PMID:
18195335
35.

Status of the epidemiology of atrial fibrillation.

Kannel WB, Benjamin EJ.

Med Clin North Am. 2008 Jan;92(1):17-40, ix. Review.

36.

Avoiding the looming Latino/Hispanic cardiovascular health crisis: a call to action.

Davidson JA, Kannel WB, Lopez-Candales A, Morales L, Moreno PR, Ovalle F, Rodriguez CJ, Rodbard HW, Rosenson RS, Stern M.

J Cardiometab Syndr. 2007 Fall;2(4):238-43. Review.

37.

Avoiding the looming Latino/Hispanic cardiovascular health crisis: a call to action.

Davidson JA, Kannel WB, Lopez-Candales A, Morales L, Moreno PR, Ovalle F, Rodriguez CJ, Rodbard HW, Rosenson RS, Stern M.

Ethn Dis. 2007 Summer;17(3):568-73. Review.

PMID:
17985515
38.

Preventing stroke: does race/ethnicity matter?

Wolf PA, Kannel WB.

Circulation. 2007 Nov 6;116(19):2099-100. No abstract available.

PMID:
17984388
39.

Plasma renin and risk of cardiovascular disease and mortality: the Framingham Heart Study.

Parikh NI, Gona P, Larson MG, Wang TJ, Newton-Cheh C, Levy D, Benjamin EJ, Kannel WB, Vasan RS.

Eur Heart J. 2007 Nov;28(21):2644-52. Epub 2007 Sep 25.

PMID:
17895253
40.

Antecedent blood pressure, body mass index, and the risk of incident heart failure in later life.

Lee DS, Massaro JM, Wang TJ, Kannel WB, Benjamin EJ, Kenchaiah S, Levy D, D'Agostino RB Sr, Vasan RS.

Hypertension. 2007 Nov;50(5):869-76. Epub 2007 Sep 24.

PMID:
17893376
41.

Are guidelines effectively guiding antihypertensive therapy?

Vasan RS, Kannel WB.

Am J Cardiol. 2007 Jul 1;100(1):143-4. Epub 2007 May 21. No abstract available.

PMID:
17599457
42.

Cardiovascular disease prevention and care in Latino and Hispanic subjects.

Davidson JA, Moreno PR, Badimon JJ, Lopez-Candales A, Maisonet Giachello AL, Ovalle F, Rodriguez CJ, Rosenson RS, Rodbard HW, Kannel WB.

Endocr Pract. 2007 Jan-Feb;13(1):77-85. Review.

PMID:
17360307
43.

Pulse pressure and risk of new-onset atrial fibrillation.

Mitchell GF, Vasan RS, Keyes MJ, Parise H, Wang TJ, Larson MG, D'Agostino RB Sr, Kannel WB, Levy D, Benjamin EJ.

JAMA. 2007 Feb 21;297(7):709-15.

PMID:
17312290
44.

Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years.

Carandang R, Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Kannel WB, Wolf PA.

JAMA. 2006 Dec 27;296(24):2939-46.

PMID:
17190894
45.

Cardiovascular disease preventive measures for the older patient: an epidemiologic perspective.

Kannel WB.

Am J Geriatr Cardiol. 2006 Nov-Dec;15(6):382-8. Review. No abstract available.

PMID:
17086034
46.

Aggressive lowering of blood pressure.

Kannel WB, Vasan RS.

Lancet. 2006 Aug 19;368(9536):627-8. No abstract available.

PMID:
16920451
47.
48.

Electrocardiographic QRS duration and the risk of congestive heart failure: the Framingham Heart Study.

Dhingra R, Pencina MJ, Wang TJ, Nam BH, Benjamin EJ, Levy D, Larson MG, Kannel WB, D'Agostino RB Sr, Vasan RS.

Hypertension. 2006 May;47(5):861-7. Epub 2006 Apr 3.

PMID:
16585411
49.

Overview of hemostatic factors involved in atherosclerotic cardiovascular disease.

Kannel WB.

Lipids. 2005 Dec;40(12):1215-20. Review.

PMID:
16477805
50.

Search for an optimal atherogenic lipid risk profile: from the Framingham Study.

Nam BH, Kannel WB, D'Agostino RB.

Am J Cardiol. 2006 Feb 1;97(3):372-5.

PMID:
16442398

Supplemental Content

Loading ...
Support Center